Sandström R, Svanberg E, Hyltander A, Haglind E, Ohlsson C, Zachrisson H, Berglund B, Lindholm E, Brevinge H, Lundholm K
Department of Surgery, Sahlgrenska University Hospital, University of Göteborg, Sweden.
Eur J Clin Invest. 1995 Oct;25(10):784-92. doi: 10.1111/j.1365-2362.1995.tb01958.x.
This study has evaluated the effects of recombinant human insulin-like growth factor I (rhIGF-I) to moderately stressed post-operative patients provided with dextrose as the only exogeneous substrate. Thirty patients who underwent elective colorectal surgery were randomized to receive either rhIGF-I (80 micrograms kg-1 bw) subcutaneously twice daily or placebo injections in a double-blind parallel group design. Nitrogen balance, urinary 3-methyl-histidine excretion plasma growth hormone (GH), serum cortisol, IGF-I binding proteins (IGFBP-1,3), glomerular filtration rate, plasma amino acid concentrations and whole-body energy expenditures were measured as effector variables during days 1-5 post-operatively. Animal and isolated tissue experiments were performed as additional control experiments to confirm cellular effectiveness of the recombinant material. rhIGF-I increased significantly the glomerular filtration rate and prevented the adaptive decrease in whole-body energy expenditure in response to partial starvation in the postoperative period. Serum and plasma concentrations of IGFBP-1,3 cortisol, blood glucose and amino acids were not significantly influenced by rhIGF-I administration, while plasma GH levels decreased significantly as expected. rhIGF-I had no effect on either nitrogen balance or protein breakdown (3-methylhistidine excretion) in post-operative patients on dextrose supplementation only, although plasma concentrations of IGF-I increased from 130-140 ng mL-1 to a range of 300-450 ng mL-1. In contrast, IGF-I stimulated the synthesis of both globular and myofibrillar proteins (+50%, P < 0.01), when given as a single dose (100 micrograms kg-1) 2 h before measurements of protein synthesis in skeletal muscles of overnight fasted adult mice. This stimulatory effect by IGF-I (1 microgram mL-1) was also confirmed by measurements of skeletal muscle protein synthesis in vitro (+40%, P < 0.05). Orally re-fed mice had a normal transcription of IGF-I mRNA in skeletal muscle cells, while overnight fasted mice showed a trend to down-regulated transcription. Our results demonstrate that rhIGF-I has several significant physiological effects, without major side-effects, when supplied to partially starved patients in the post-operative phase. The lack of a whole-body nitrogen sparing effect by rhIGF-I alone to post-operative patients is not clear, but was most likely explained by subnormal plasma concentrations of amino acids.
本研究评估了重组人生长激素释放因子(rhIGF-I)对仅接受葡萄糖作为唯一外源性底物的中度应激术后患者的影响。30例行择期结直肠手术的患者被随机分为两组,采用双盲平行组设计,分别接受皮下注射rhIGF-I(80微克/千克体重),每日两次,或安慰剂注射。术后第1至5天,测量氮平衡、尿3-甲基组氨酸排泄、血浆生长激素(GH)、血清皮质醇、IGF-I结合蛋白(IGFBP-1,3)、肾小球滤过率、血浆氨基酸浓度和全身能量消耗作为效应变量。进行动物和离体组织实验作为额外的对照实验,以证实重组物质的细胞有效性。rhIGF-I显著提高了肾小球滤过率,并防止了术后因部分饥饿引起的全身能量消耗的适应性下降。rhIGF-I给药对IGFBP-1,3、皮质醇、血糖和氨基酸的血清及血浆浓度无显著影响,而血浆GH水平如预期显著下降。仅补充葡萄糖的术后患者,rhIGF-I对氮平衡或蛋白质分解(3-甲基组氨酸排泄)均无影响,尽管血浆IGF-I浓度从130 - 140纳克/毫升增加到300 - 450纳克/毫升。相反,在测量过夜禁食成年小鼠骨骼肌蛋白质合成前2小时,给予单剂量(100微克/千克)的IGF-I可刺激球蛋白和肌原纤维蛋白的合成(增加50%,P < 0.01)。体外测量骨骼肌蛋白质合成也证实了IGF-I(1微克/毫升)的这种刺激作用(增加40%,P < 0.05)。经口再喂养的小鼠骨骼肌细胞中IGF-I mRNA转录正常,而过夜禁食的小鼠则呈现转录下调趋势。我们的结果表明,术后向部分饥饿的患者提供rhIGF-I具有多种显著的生理效应,且无重大副作用。rhIGF-I单独对术后患者缺乏全身氮节约效应的原因尚不清楚,但很可能是由于血浆氨基酸浓度低于正常水平所致。